Celularity (CELU) Cash from Operations (2019 - 2025)
Celularity (CELU) posted quarterly Cash from Operations of 5103000.0 for Q4 2025, down 420.14% year-over-year from 1594000.0 in Q4 2024, and down 22.7% quarter-over-quarter from 4159000.0 in Q3 2025.
Celularity (CELU) Cash from Operations (2019 - 2025) Analysis & Trends
Celularity (CELU) has reported Cash from Operations for 7 consecutive years, with 5103000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Operations fell 420.14% year-over-year to 5103000.0; the TTM figure through Dec 2025 stood at 13254000.0 (down 107.06% YoY), while the FY2025 annual figure was 13254000.0, down 107.06% from the prior year.
- Cash from Operations slipped to 5103000.0 in Q4 2025 per CELU's latest filing, from 4159000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 1594000.0 in Q4 2024 and bottomed at 37720000.0 in Q3 2022.
- Historically, Cash from Operations has averaged 15315600.0 across 5 years, with a median of 9674500.0 in 2023.
- Annual changes were most pronounced in 2021 — Cash from Operations plunged 8009.32% — and 2024, when it surged 136.72%.
- Celularity's Cash from Operations stood at 32045000.0 in 2021, then rose by 7.68% to 29585000.0 in 2022, then surged by 85.33% to 4341000.0 in 2023, then soared by 136.72% to 1594000.0 in 2024, then plunged by 420.14% to 5103000.0 in 2025.
- Business Quant data shows CELU's Cash from Operations at 5103000.0 in Q4 2025, 4159000.0 in Q3 2025, and 999000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn | -5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.10 Mn |
| Dec 31, 2025 | -5.10 Mn |
| Sep 30, 2025 | -4.16 Mn |
| Sep 30, 2025 | -4.16 Mn |
| Jun 30, 2025 | -999,000.00 |
| Jun 30, 2025 | -999,000.00 |
| Mar 31, 2025 | -2.99 Mn |
| Mar 31, 2025 | -2.99 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Sep 30, 2024 | -144,000.00 |
| Sep 30, 2024 | -144,000.00 |
| Jun 30, 2024 | -3.45 Mn |
| Jun 30, 2024 | -3.45 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -4.34 Mn |
| Dec 31, 2023 | -4.34 Mn |
| Sep 30, 2023 | -8.32 Mn |
| Sep 30, 2023 | -8.32 Mn |